
Andrew McConaghie
Senior Writer at Scrip
Senior Writer, Scrip. Pharma and healthcare updates
Articles
-
1 week ago |
insights.citeline.com | Andrew McConaghie
Senti’s Computer-Logic Inspired Cell Therapy Shows Early PromiseThe biotech believes its logic-gated cell therapies can get round the need for ‘clean targets’ which limit CAR-Ts and ADCs.NK Cells Attacking A Cancer Cell • Source: Shutterstock
-
2 weeks ago |
insights.citeline.com | Andrew McConaghie
Merus’ Bispecific Impresses In Head And Neck CancerUpdated Phase II results from petosemtamab have impressed ahead of ASCO, outshining Keytruda monotherapy and its bispecific rival from Bicara.
-
2 weeks ago |
insights.citeline.com | Andrew McConaghie
PureTech’s IPF Candidate Ready For Phase III After Efficacy WinComing one day after Boehringer’s underwhelming data, PureTech’s tweaked molecule, deupirfenidone, shows more promise in slowing idiopathic pulmonary fibrosis.
-
2 weeks ago |
insights.citeline.com | Andrew McConaghie
-
3 weeks ago |
insights.citeline.com | Andrew McConaghie
Novo Nordisk’s CEO Forced Out After Falling Behind In GLP-1 BattleCompany surprises investors with Jørgensen's exit but insists its strategy will not change.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 1K
- Tweets
- 3K
- DMs Open
- No

RT @LBC: ❌ Ukraine started the war ❌ America provides more funding than Europe ❌ Ukraine needs immediate elections Sir Ben Wallace fact…

RT @MrBrendanCox: Please vote. https://t.co/u0Cw2aPDVD

Madrigal has just gained the first ever MASH (NASH) drug approval - but there's plenty of competition coming. $MDGL $AKRO $ETNB $VKTX @ByLizC https://t.co/FC05gvO0kB